In silico Investigation of the Antidiabetic Potential of Putranjiva roxburghii Phytoconstituents
International Journal of Drug Delivery Technology · 06.07.2026 · 16 (62s)
DOI: 10.25258/ijddt.16.62s.182 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 06.07.2026. Verfasst von Mahvish Jamal und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by impaired insulin secretion and insulin resistance, leading to persistent hyperglycemia and associated complications. Inhibition of carbohydrate-hydrolyzing enzymes such as α-amylase represents an effective strategy for controlling postprandial blood glucose levels. Putranjiva roxburghii, a medicinal plant widely used in traditional systems of medicine, contains numerous bioactive phytoconstituents with potential therapeutic applications.
Objective
The present study aimed to investigate the antidiabetic potential of phytoconstituents from Putranjiva roxburghii through molecular docking against α-amylase (PDB ID: 2QV4).
Methods
Thirty phytoconstituents reported from P. roxburghii were selected for in silico analysis. The threedimensional structures of the ligands were prepared using ChemDraw and Chem3D, while molecular docking studies were performed using AutoDock Vina. Binding affinities and protein–ligand interactions were evaluated within the active site of α-amylase, and interactions with key catalytic residues were analyzed.
Results
Docking scores ranged from –5.8 to –12.3 kcal/mol. Among the screened compounds, Amentoflavone and Putraflavone exhibited the highest binding affinity (–12.3 kcal/mol), followed by 4'''-O-methylamentoflavone (–9.9 kcal/mol), 3-O-methyl ellagic acid-4-O-α-rhamnopyranoside (–9.5 kcal/mol), Putrol (–9.4 kcal/mol), Putron (–9.4 kcal/mol), Catechin (–9.1 kcal/mol), and Gallocatechin (–9.0 kcal/mol). These compounds formed multiple hydrogenbond, hydrophobic, π–π stacking, and electrostatic interactions with crucial active-site residues, including TRP59, TYR62, GLN63, ARG195, GLU233, HIS299, and ASP300. Several phytoconstituents demonstrated interaction patterns comparable to those of the co-crystallized ligand, indicating strong binding within the catalytic pocket of αamylase.
Conclusion
The findings suggest that Putranjiva roxburghii is a promising source of antidiabetic phytochemicals. Amentoflavone and Putraflavone emerged as the most potent α-amylase inhibitors among the screened compounds and may serve as lead molecules for the development of novel antidiabetic agents. Further in vitro, in vivo, and pharmacokinetic studies are warranted to validate their therapeutic potential.
Zitieren
APA
Jamal, M., & Singh, M. (2026). In silico Investigation of the Antidiabetic Potential of Putranjiva roxburghii Phytoconstituents. International Journal of Drug Delivery Technology, 16(62s). https://doi.org/10.25258/ijddt.16.62s.182
Vancouver
Jamal M, Singh M. In silico Investigation of the Antidiabetic Potential of Putranjiva roxburghii Phytoconstituents. International Journal of Drug Delivery Technology. 2026;16(62s). doi:10.25258/ijddt.16.62s.182
BibTeX
@article{Jamal2026,
author = {Jamal, Mahvish and Singh, Mhaveer},
title = {In silico Investigation of the Antidiabetic Potential of Putranjiva roxburghii Phytoconstituents},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {62s},
doi = {10.25258/ijddt.16.62s.182}
}
EUVIMED